Fillmore, C. M., Xu, C., Desai, P. T., Berry, J. M., Rowbotham, S. P., Lin, Y., . . . Kim, C. F. (2015). EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors. Nature.
Citación estilo ChicagoFillmore, Christine M., et al. "EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumors to TopoII Inhibitors." Nature 2015.
Cita MLAFillmore, Christine M., et al. "EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumors to TopoII Inhibitors." Nature 2015.
Precaución: Estas citas no son 100% exactas.